In January 2017 Dr. Michael Graber was awarded the Best Basic Research Poster of the Integrated Management of Acute and Chronic Cardiovascular Disease Congress in Innsbruck for our work on the calcific aortic valve disease.
Title of his poster:
Inhibition of Toll-Like receptor 3 prevents from calcific aortic valve disease.
Graber M, Pölzl L, Hirsch J, Kirchmair E, Degenhart G, Lobenwein D, Fuchs C, Grimm M, Holfeld J, Tepeköylü C.